The Role of Hypoxia-induced MiR-210 in Cancer Progression

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2015 Mar 27

PMID 25809609

Citations 79

Authors

Kyvan Dang

Kenneth A Myers

Affiliations

Soon will be listed here.

Abstract

Prolonged hypoxia, the event of insufficient oxygen, is known to upregulate tumor development and growth by promoting the formation of a neoplastic environment. The recent discovery that a subset of cellular microRNAs (miRs) are upregulated during hypoxia, where they function to promote tumor development, highlights the importance of hypoxia-induced miRs as targets for continued investigation. miRs are short, non-coding transcripts involved in gene expression and regulation. Under hypoxic conditions, miR-210 becomes highly upregulated in response to hypoxia inducing factors (HIFs). HIF-1α drives miR-210's overexpression and the resultant alteration of cellular processes, including cell cycle regulation, mitochondria function, apoptosis, angiogenesis and metastasis. Here we discuss hypoxia-induced dysregulation of miR-210 and the resultant changes in miR-210 protein targets that regulate cancer progression. Potential methods of targeting miR-210 as a therapeutic tool are also explored.

Citing Articles

Unveiling Novel miRNA-mRNA Interactions and Their Prognostic Roles in Triple-Negative Breast Cancer: Insights into miR-210, miR-183, miR-21, and miR-181b.

Xu J, Cai X, Huang J, Huang H, Wang Y, Ji X Int J Mol Sci. 2025; 26(5).

PMID: 40076546 PMC: 11899986. DOI: 10.3390/ijms26051916.

Strategies to Overcome Intrinsic and Acquired Resistance to Chemoradiotherapy in Head and Neck Cancer.

de Bakker T, Maes A, Dragan T, Martinive P, Penninckx S, Van Gestel D Cells. 2025; 14(1.

PMID: 39791719 PMC: 11719474. DOI: 10.3390/cells14010018.

miR-210 loss leads to widespread phenotypic and gene expression changes in human 293T cells.

Zhang X, Meng Z, Yang C, Wang C, Zhang K, Shi A Front Genet. 2024; 15:1486252.

PMID: 39737000 PMC: 11683127. DOI: 10.3389/fgene.2024.1486252.

miR-210 Mediated Hypoxic Responses in Pancreatic Ductal Adenocarcinoma.

Mortoglou M, Lian M, Miralles F, Dart D, Uysal-Onganer P ACS Omega. 2024; 9(48):47872-47883.

PMID: 39651070 PMC: 11618397. DOI: 10.1021/acsomega.4c08947.

Mono-(2-ethylhexyl) phthalate induces trophoblast hypoxia and mitochondrial dysfunction through HIF-1α-miR-210-3p axis in HTR-8/SVneo cell line.

Meruvu S, Ding Z, Choudhury M Curr Res Toxicol. 2024; 7:100188.

PMID: 39175913 PMC: 11338994. DOI: 10.1016/j.crtox.2024.100188.

References

Ellermeier C, Vang S, Cleveland K, Durand W, Resnick M, Brodsky A . Prognostic microRNA expression signature from examination of colorectal primary and metastatic tumors. Anticancer Res. 2014; 34(8):3957-67. View

Faraonio R, Salerno P, Passaro F, Sedia C, Iaccio A, Bellelli R . A set of miRNAs participates in the cellular senescence program in human diploid fibroblasts. Cell Death Differ. 2011; 19(4):713-21. PMC: 3307984. DOI: 10.1038/cdd.2011.143. View

Xie J, Burt D, Gao G . Adeno-associated virus-mediated microRNA delivery and therapeutics. Semin Liver Dis. 2015; 35(1):81-8. PMC: 4460833. DOI: 10.1055/s-0034-1397352. View

Chang W, Lee C, Park J, Park M, Maeng L, Yoon C . Survival of hypoxic human mesenchymal stem cells is enhanced by a positive feedback loop involving miR-210 and hypoxia-inducible factor 1. J Vet Sci. 2013; 14(1):69-76. PMC: 3615234. DOI: 10.4142/jvs.2013.14.1.69. View

Baigude H, McCarroll J, Yang C, Swain P, Rana T . Design and creation of new nanomaterials for therapeutic RNAi. ACS Chem Biol. 2007; 2(4):237-41. DOI: 10.1021/cb7000582. View

Lees J, Saito M, Vidal M, Valentine M, Look T, Harlow E . The retinoblastoma protein binds to a family of E2F transcription factors. Mol Cell Biol. 1993; 13(12):7813-25. PMC: 364853. DOI: 10.1128/mcb.13.12.7813-7825.1993. View

Tessitore A, Cicciarelli G, Del Vecchio F, Gaggiano A, Verzella D, Fischietti M . MicroRNAs in the DNA Damage/Repair Network and Cancer. Int J Genomics. 2014; 2014:820248. PMC: 3926391. DOI: 10.1155/2014/820248. View

Cui H, Seubert B, Stahl E, Dietz H, Reuning U, Moreno-Leon L . Tissue inhibitor of metalloproteinases-1 induces a pro-tumourigenic increase of miR-210 in lung adenocarcinoma cells and their exosomes. Oncogene. 2014; 34(28):3640-50. DOI: 10.1038/onc.2014.300. View

Tadokoro H, Umezu T, Ohyashiki K, Hirano T, Ohyashiki J . Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells. J Biol Chem. 2013; 288(48):34343-51. PMC: 3843049. DOI: 10.1074/jbc.M113.480822. View

10.

Zhang Y, Wang Z, Gemeinhart R . Progress in microRNA delivery. J Control Release. 2013; 172(3):962-74. PMC: 3891846. DOI: 10.1016/j.jconrel.2013.09.015. View

11.

Tsuchiya S, Fujiwara T, Sato F, Shimada Y, Tanaka E, Sakai Y . MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1). J Biol Chem. 2010; 286(1):420-8. PMC: 3013001. DOI: 10.1074/jbc.M110.170852. View

12.

Krutzfeldt J, Kuwajima S, Braich R, Rajeev K, Pena J, Tuschl T . Specificity, duplex degradation and subcellular localization of antagomirs. Nucleic Acids Res. 2007; 35(9):2885-92. PMC: 1888827. DOI: 10.1093/nar/gkm024. View

13.

Qin Q, Furong W, Baosheng L . Multiple functions of hypoxia-regulated miR-210 in cancer. J Exp Clin Cancer Res. 2014; 33:50. PMC: 4060094. DOI: 10.1186/1756-9966-33-50. View

14.

Qu A, Du L, Yang Y, Liu H, Li J, Wang L . Hypoxia-inducible MiR-210 is an independent prognostic factor and contributes to metastasis in colorectal cancer. PLoS One. 2014; 9(3):e90952. PMC: 3954583. DOI: 10.1371/journal.pone.0090952. View

15.

Giannakakis A, Sandaltzopoulos R, Greshock J, Liang S, Huang J, Hasegawa K . miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Cancer Biol Ther. 2007; 7(2):255-64. PMC: 3233968. DOI: 10.4161/cbt.7.2.5297. View

16.

Shang C, Hong Y, Guo Y, Liu Y, Xue Y . MiR-210 up-regulation inhibits proliferation and induces apoptosis in glioma cells by targeting SIN3A. Med Sci Monit. 2014; 20:2571-7. PMC: 4266365. DOI: 10.12659/MSM.892994. View

17.

Yang W, Wei J, Sun T, Liu F . Effects of knockdown of miR-210 in combination with ionizing radiation on human hepatoma xenograft in nude mice. Radiat Oncol. 2013; 8:102. PMC: 3661404. DOI: 10.1186/1748-717X-8-102. View

18.

Sehgal A, Vaishnaw A, FitzGerald K . Liver as a target for oligonucleotide therapeutics. J Hepatol. 2013; 59(6):1354-9. DOI: 10.1016/j.jhep.2013.05.045. View

19.

Voorhoeve P . MicroRNAs: Oncogenes, tumor suppressors or master regulators of cancer heterogeneity?. Biochim Biophys Acta. 2009; 1805(1):72-86. DOI: 10.1016/j.bbcan.2009.09.003. View

20.

Ivan M, Harris A, Martelli F, Kulshreshtha R . Hypoxia response and microRNAs: no longer two separate worlds. J Cell Mol Med. 2008; 12(5A):1426-31. PMC: 3918058. DOI: 10.1111/j.1582-4934.2008.00398.x. View